EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027

Market By Drugs & Devices And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research has estimated the Europe ophthalmology drugs and devices market to show upward growth and expand with a CAGR of 5.99% in the forecasting years 2019-2027.

The countries that have been analyzed in Europe’s ophthalmology drugs and devices market are:

•           The United Kingdom

•           France

•           Germany

•           Spain

•           Italy

•           Russia

•           Rest of Europe

Report scope can be customized per your requirements. Request For Customization

The United Kingdom ophthalmology drugs and devices market is mainly driven by the escalating prevalence of ophthalmological disorders. According to the Royal National Institute of Blind People, age-related macular degeneration is the leading cause of blindness in the adult population, which is further followed by glaucoma, diabetic retinopathy and cataracts sight loss disorders. According to the institute, every day, around 250 people are beginning to lose their sight in the United Kingdom. As of the year 2015, more than 2 million individuals in the United Kingdom were reported to be living with eyesight disorders. According to the Royal Institute of Blind People, the number of individuals impacted by sight loss is expected to increase to around 2.7 million by the end of 2030; whereas, by the end of 2050, it is anticipated to reach around 4 million, which is further augmenting the growth of the ophthalmology drugs and devices market in the country.

The France ophthalmology drugs and devices market is mainly driven owing to the escalating prevalence of ophthalmological disorders, which mainly includes retinal vein occlusions and diabetic retinopathy. According to the European Society of Retina Specialists, approximately 85,000 individuals were affected by diabetic eye disease in 2017, which is anticipated to reach around 3 million by the end of 2050. The rising screening of diabetic retinopathy in France is estimated to be around 68%, which is precisely performed by fundoscopy in private ophthalmology practices in the country; this is paving the growth of the ophthalmology drugs and devices market in the country. According to the European Society of Retina Specialists, above 1 million individuals were estimated to be affected by retinal vein occlusions in 2017, which is anticipated to reach around 1.5 million by the end of 2050, further augmenting the growth of the ophthalmology drugs and devices market in the country.

Bayer AG is a Germany-based life sciences company, operating in verticals such as consumer health, pharmaceuticals, animal health and crop science. The company’s pharmaceuticals segment is engaged in the development of prescription pharmaceuticals; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic procedures. In 2015, the company generated revenue worth $4103 million.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCE ANALYSIS

2.1.1.   BARGAINING POWER OF BUYERS

2.1.2.   BARGAINING POWER OF SUPPLIER

2.1.3.   THREATS OF NEW ENTRANTS

2.1.4.   THREATS OF SUBSTITUTES

2.1.5.   COMPETITIVE RIVALRY

2.2. STRATEGIC OUTLOOK

2.3. KEY INSIGHT

2.4. VALUE CHAIN OUTLOOK

2.5. KEY BUYING STANDARDS

2.6. SUPPLY CHAIN OUTLOOK

2.7. REGULATORY FRAMEWORK

2.8. MARKET DRIVERS

2.8.1.   INCREASING OPHTHALMIC DISORDERS DUE TO HIGH BLOOD SUGAR

2.8.2.   UPSURGE IN HEALTHCARE SPENDING

2.8.3.   TECHNOLOGICAL ADVANCEMENT

2.9. MARKET RESTRAINTS

2.9.1.   EXPIRATIONS OF BRAND PATENTS HAVE AFFECTED THE PHARMACEUTICAL INDUSTRY

2.9.2.   LOW COGNIZANCE RELATED TO OPHTHALMIC DRUGS

2.9.3.   DRUG APPROVALS DELAY AND NUMBER OF DRUGS IN THE PIPELINE

2.10.            MARKET OPPORTUNITIES

2.10.1.                DEMAND FOR PHACOEMULSIFICATION DEVICES AND INTRAOCULAR LENSES IS INCREASING

2.11.            MARKET CHALLENGES

2.11.1.                DIFFICULTIES ASSOCIATED WITH THE CONDUCT OF OCULAR DISEASES

3.    OPHTHALMOLOGY DRUGS AND DEVICES MARKET OUTLOOK - BY DRUGS AND DEVICES

3.1. DEVICES

3.1.1.   DIAGNOSTIC & MONITORING EQUIPMENT

3.1.1.1.      OPTICAL COHERENCE TOMOGRAPHY

3.1.1.2.      OPHTHALMIC ULTRASOUND IMAGING SYSTEMS

3.1.1.3.      FUNDUS CAMERA MARKET

3.1.1.4.      OPHTHALMOSCOPES

3.1.1.5.      RETINOSCOPE

3.1.1.6.      PACHYMETER

3.1.1.7.      WAVEFRONT ABERROMETERS

3.1.1.8.      PERIMETERS/VISUAL FIELD ANALYZER

3.1.1.9.      AUTOREFRACTORS/PHOROPTER

3.1.1.10.   SPECULAR MICROSCOPE

3.1.1.11.   CORNEAL TOPOGRAPHERS

3.1.1.12.   OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET

3.1.2.   SURGERY DEVICES

3.1.2.1.      CATARACT SURGERY DEVICES

3.1.2.2.      GLAUCOMA SURGERY DEVICES

3.1.2.3.      REFRACTIVE SURGERY DEVICES

3.1.2.4.      VITREORETINAL SURGERY DEVICES

3.1.3.   VISION CARE

3.2. DRUGS

3.2.1.   GLAUCOMA DRUG

3.2.2.   RETINAL DISORDER DRUG

3.2.3.   DRY EYE DRUG

3.2.4.   ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG

3.2.5.   DRUGS BY USE OF PRESERVATION

3.2.5.1.      PRESERVED DRUGS

3.2.5.2.      PRESERVATIVE-FREE DRUGS

4.    OPHTHALMOLOGY DRUGS AND DEVICES MARKET - REGIONAL OUTLOOK

4.1. THE UNITED KINGDOM

4.2. FRANCE

4.3. GERMANY

4.4. SPAIN

4.5. ITALY

4.6. RUSSIA

4.7. REST OF EUROPE

5.    COMPETITIVE LANDSCAPE

5.1. ALLERGAN, INC.

5.2. BAYER

5.3. CARL ZEISS AG

5.4. ESSILOR INTERNATIONAL S.A.

5.5. GLAXOSMITHKLINE

5.6. JOHNSON & JOHNSON, INC.

5.7. NOVARTIS INTERNATIONAL AG

5.8. PFIZER

5.9. ROCHE HOLDING AG

5.10.            SANTEN PHARMACEUTICAL CO., LTD.

5.11.            SUN PHARMACEUTICALS INDUSTRIES, LTD.

5.12.            VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

5.13.            ZIEMER GROUP HOLDING AG

6.    METHODOLOGY AND SCOPE

6.1. RESEARCH SCOPE

6.2. SOURCES OF DATA

6.3. RESEARCH METHODOLOGY

List of table

TABLE 1        EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

TABLE 2        COMMON CAUSES OF LOSS OF VISION IN THE ELDERLY

TABLE 3        SELECTED LIST OF GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS

TABLE 4        EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 5        EUROPE DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT BY TYPES 2019-2027 ($ MILLION)

TABLE 6        EUROPE DEVICES MARKET IN SURGERY DEVICE BY TYPES 2019-2027 ($ MILLION)

TABLE 7        EUROPE DRUGS AND DEVICES MARKET IN DRUGS BY TYPES 2019-2027 ($ MILLION)

TABLE 8        EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027                  

FIGURE 2      EUROPE DRUGS AND DEVICES MARKET IN DEVICES 2019-2027 ($ MILLION)                       

FIGURE 3      EUROPE DEVICES MARKET DIAGNOSTIC & MONITORING EQUIPMENT IN 2019-2027 ($ MILLION)               

FIGURE 4      EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY 2019-2027 ($ MILLION)                    

FIGURE 5      EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 2019-2027 ($ MILLION)                      

FIGURE 6      EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2019-2027 ($ MILLION)                 

FIGURE 7      EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2019-2027 ($ MILLION)                      

FIGURE 8      EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2019-2027 ($ MILLION)                 

FIGURE 9      EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER 2019-2027 ($ MILLION)                 

FIGURE 10   EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2019-2027 ($ MILLION)                  

FIGURE 11   EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER 2019-2027 ($ MILLION)            

FIGURE 12   EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2019-2027 ($ MILLION)                       

FIGURE 13   EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2019-2027 ($ MILLION)             

FIGURE 14   EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2019-2027 ($ MILLION)                  

FIGURE 15   EUROPE DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2019-2027 ($ MILLION)              

FIGURE 16   EUROPE DEVICES MARKET IN SURGERY DEVICE 2019-2027 ($ MILLION)                 

FIGURE 17   EUROPE SURGERY DEVICES MARKET IN CATARACT SURGERY DEVICES 2019-2027 ($ MILLION)               

FIGURE 18   EUROPE SURGERY DEVICES MARKET IN GLAUCOMA SURGERY DEVICES 2019-2027 ($ MILLION)                 

FIGURE 19   EUROPE SURGERY DEVICES MARKET IN REFRACTIVE SURGERY DEVICES 2019-2027 ($ MILLION)                 

FIGURE 20   EUROPE SURGERY DEVICES MARKET IN VITREORETINAL SURGERY DEVICES 2019-2027 ($ MILLION)                 

FIGURE 21   EUROPE DEVICES MARKET IN VISION CARE MARKET 2019-2027 ($ MILLION)                       

FIGURE 22   EUROPE DRUGS AND DEVICES MARKET IN DRUGS 2019-2027 ($ MILLION)             

FIGURE 23   EUROPE DRUGS MARKET IN GLAUCOMA DRUG 2019-2027 ($ MILLION)                    

FIGURE 24   EUROPE DRUGS MARKET IN RETINAL DISORDER DRUG 2019-2027 ($ MILLION)                       

FIGURE 25   EUROPE DRUGS MARKET IN DRY EYE DRUG 2019-2027 ($ MILLION) 

FIGURE 26   EUROPE DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2019-2027 ($ MILLION)                  

FIGURE 27   EUROPE DRUGS BY USE OF PRESERVATION IN PRESERVED DRUGS 2019-2027 ($ MILLION)               

FIGURE 28   EUROPE DRUGS BY USE OF PRESERVATION IN PRESERVATIVE-FREE DRUGS 2019-2027 ($ MILLION)                 

FIGURE 29   EUROPE PRESERVATIVE-FREE DRUGS MARKET IN SINGLE-DOSE 2019-2027 ($ MILLION)                  

FIGURE 30   EUROPE PRESERVATIVE-FREE DRUGS MARKET IN MULTI-DOSE 2019-2027 ($ MILLION)                  

FIGURE 31   THE UNITED KINGDOM OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                 

FIGURE 32   FRANCE OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                  

FIGURE 33   GERMANY OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                  

FIGURE 34   SPAIN OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                  

FIGURE 35   ITALY OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                  

FIGURE 36   RUSSIA OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                  

FIGURE 37   REST OF EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)    

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;